$CHUC
Charlie's Holdings, Inc.

2023 Q3 Form 10-Q Financial Statement

#000143774923023663 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $2.706M $3.970M
YoY Change -57.9% -46.33%
Cost Of Revenue $1.609M $1.879M
YoY Change -56.17% -58.78%
Gross Profit $1.097M $2.091M
YoY Change -60.2% -26.35%
Gross Profit Margin 40.54% 52.67%
Selling, General & Admin $1.798M $2.094M
YoY Change -33.43% -21.19%
% of Gross Profit 163.9% 100.14%
Research & Development $41.00K $39.00K
YoY Change 355.56% -94.76%
% of Gross Profit 3.74% 1.87%
Depreciation & Amortization $37.00K $38.00K
YoY Change -32.73% -68.85%
% of Gross Profit 3.37% 1.82%
Operating Expenses $3.448M $4.012M
YoY Change -45.96% -49.59%
Operating Profit -$742.0K $42.00K
YoY Change -1713.04% -107.47%
Interest Expense $121.0K $111.0K
YoY Change 1628.57% 21.98%
% of Operating Profit 264.29%
Other Income/Expense, Net $34.00K $74.00K
YoY Change -85.83% -200.0%
Pretax Income -$708.0K $32.00K
YoY Change -347.55% -105.03%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$708.0K $32.00K
YoY Change -393.78% -105.03%
Net Earnings / Revenue -26.16% 0.81%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 224.6M 224.1M
Diluted Shares Outstanding 216.7M 245.3M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $739.0K $343.0K
YoY Change 58.58% -29.71%
Cash & Equivalents $739.0K $343.0K
Short-Term Investments
Other Short-Term Assets $793.0K $453.0K
YoY Change -16.53% -49.44%
Inventory $3.783M $3.031M
Prepaid Expenses
Receivables $489.0K $522.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.804M $4.349M
YoY Change -28.35% -50.58%
LONG-TERM ASSETS
Property, Plant & Equipment $194.0K $231.0K
YoY Change -44.89% -30.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $101.0K $101.0K
YoY Change 14.77% 23.17%
Total Long-Term Assets $817.0K $949.0K
YoY Change -38.39% -0.42%
TOTAL ASSETS
Total Short-Term Assets $5.804M $4.349M
Total Long-Term Assets $817.0K $949.0K
Total Assets $6.621M $5.298M
YoY Change -30.09% -45.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.293M $977.0K
YoY Change -14.14% -59.94%
Accrued Expenses $1.321M $1.186M
YoY Change -19.25% -25.36%
Deferred Revenue $142.0K $73.00K
YoY Change -42.04% -64.04%
Short-Term Debt $1.500M $300.0K
YoY Change 403.36%
Long-Term Debt Due $200.0K $115.0K
YoY Change -80.0% -88.5%
Total Short-Term Liabilities $5.682M $3.557M
YoY Change 7.21% -40.72%
LONG-TERM LIABILITIES
Long-Term Debt $1.072M $1.094M
YoY Change 614.67% 629.33%
Other Long-Term Liabilities $115.0K $223.0K
YoY Change -78.14% -29.87%
Total Long-Term Liabilities $1.187M $1.317M
YoY Change 75.59% 181.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.682M $3.557M
Total Long-Term Liabilities $1.187M $1.317M
Total Liabilities $6.869M $4.874M
YoY Change 15.6% -24.81%
SHAREHOLDERS EQUITY
Retained Earnings -$8.513M -$7.805M
YoY Change 87.35% 63.11%
Common Stock $225.0K $225.0K
YoY Change 3.21% 3.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$248.0K $424.0K
YoY Change
Total Liabilities & Shareholders Equity $6.621M $5.298M
YoY Change -30.09% -45.6%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$708.0K $32.00K
YoY Change -393.78% -105.03%
Depreciation, Depletion And Amortization $37.00K $38.00K
YoY Change -32.73% -68.85%
Cash From Operating Activities -$860.0K $365.0K
YoY Change 249.59% -140.38%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.256M -405.0K
YoY Change 318.67% -140.5%
NET CHANGE
Cash From Operating Activities -860.0K 365.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 1.256M -405.0K
Net Change In Cash 396.0K -40.00K
YoY Change -1900.0% -150.63%
FREE CASH FLOW
Cash From Operating Activities -$860.0K $365.0K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$860.0K $365.0K
YoY Change 405.88% -141.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
219163631
CY2023Q2 us-gaap Inventory Net
InventoryNet
3031000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
453000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
4349000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
dei Entity Central Index Key
EntityCentralIndexKey
0001134765
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2023Q2 us-gaap Cash
Cash
343000 usd
CY2022Q4 us-gaap Cash
Cash
257000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
522000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1161000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
3652000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
780000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
5850000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
231000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
617000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
799000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
101000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
949000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1211000 usd
CY2023Q2 us-gaap Assets
Assets
5298000 usd
CY2022Q4 us-gaap Assets
Assets
7061000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2450000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2333000 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
221000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
629000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
398000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
373000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
73000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
148000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3557000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4783000 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1094000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
150000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
223000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
428000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1317000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
578000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
4874000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5361000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1800000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
219163631
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
225000 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
219000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8004000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7928000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7805000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6447000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1700000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5298000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7061000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
15471000 usd
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
5018000 usd
chuc Cost Of Goods Sold Product Revenue
CostOfGoodsSoldProductRevenue
8992000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3763000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4429000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
687000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1490000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91000 usd
us-gaap Operating Expenses
OperatingExpenses
15666000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1559000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
195000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
91000 usd
us-gaap Interest Expense
InterestExpense
242000 usd
us-gaap Interest Expense
InterestExpense
92000 usd
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
12000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
408000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
352000 usd
CY2022Q2 us-gaap Other Income
OtherIncome
5000 usd
us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
5000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-74000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
201000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
265000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
32000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-636000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1358000 usd
us-gaap Net Income Loss
NetIncomeLoss
70000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-327000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
141000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
14000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
117000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-26000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-75000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216372777
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212051322
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214987456
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211532305
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
245299090
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212051322
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214987456
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
242800474
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
355000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
37000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
32000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3855000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
38000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-636000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1700000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
82000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1358000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
56000 usd
us-gaap Net Income Loss
NetIncomeLoss
70000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3257000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1358000 usd
us-gaap Net Income Loss
NetIncomeLoss
70000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
187000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
80000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
189000 usd
us-gaap Accretion Expense
AccretionExpense
132000 usd
us-gaap Accretion Expense
AccretionExpense
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
13000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
408000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
352000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
35000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
182000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
215000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
82000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
56000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
118000 usd
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
308000 usd
chuc Adjustments Noncash Items And Net Income Loss To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsAndNetIncomeLossToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1240000 usd
chuc Adjustments Noncash Items And Net Income Loss To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsAndNetIncomeLossToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
378000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-554000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
587000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-621000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
629000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-35000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-180000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-222000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1276000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-102000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
630000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
668000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-38000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
86000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-378000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
257000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
866000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
343000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
488000 usd
us-gaap Interest Paid Net
InterestPaidNet
145000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
chuc Interest Paid Net Related Party
InterestPaidNetRelatedParty
-15000 usd
chuc Interest Paid Net Related Party
InterestPaidNetRelatedParty
-0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
106000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
2000 usd
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Operating Income Loss
OperatingIncomeLoss
1559000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1358000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
124000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
424000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; "><i>Use of Estimates</i></span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
629000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
408000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
221000 usd
CY2019Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
27500000 usd
CY2019Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.44313
us-gaap Depreciation And Amortization
DepreciationAndAmortization
80000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
189000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1036000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1036000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
805000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
725000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
231000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
977000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1222000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
635000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
631000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
129000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
137000 usd
CY2023Q2 chuc Customer Deposit Current
CustomerDepositCurrent
556000 usd
CY2022Q4 chuc Customer Deposit Current
CustomerDepositCurrent
119000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
153000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
224000 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2450000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2333000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
417000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
975000 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q2 chuc Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
150000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1542000 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-33000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1509000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-636000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1358000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
70000 usd
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
185000 usd
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
352000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-153000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-636000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1358000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-282000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216372777
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212051322
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214987456
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211532305
CY2023Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
28926313
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
31268169
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
245299090
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212051322
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214987456
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
242800474
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
75076000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46548000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6003000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.56
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y4M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
191000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.46
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5812000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
5805000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
0.56
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
621000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
617000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
113000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
116000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
225000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
255000 usd
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
113000 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
116000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
225000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
255000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
5000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
3000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
118000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
119000 usd
us-gaap Lease Cost
LeaseCost
235000 usd
us-gaap Lease Cost
LeaseCost
258000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
202000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
261000 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y6M29D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.120 pure
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
202000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
385000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
75000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
662000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
41000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
621000 usd

Files In Submission

Name View Source Status
chuc-20230630_cal.xml Edgar Link unprocessable
0001437749-23-023663-index-headers.html Edgar Link pending
0001437749-23-023663-index.html Edgar Link pending
0001437749-23-023663.txt Edgar Link pending
0001437749-23-023663-xbrl.zip Edgar Link pending
chuc-20230630.xsd Edgar Link pending
chuc20230630_10q.htm Edgar Link pending
ex_555075.htm Edgar Link pending
ex_555076.htm Edgar Link pending
ex_555077.htm Edgar Link pending
ex_555078.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
chuc-20230630_def.xml Edgar Link unprocessable
chuc-20230630_lab.xml Edgar Link unprocessable
chuc-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chuc20230630_10q_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending